MYRIAD GENETICS, INC. Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
MYRIAD GENETICS, INC. (MYGN) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay of 4.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent · last filed 2026-02-24
- MYRIAD GENETICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2025 was 4.00%, a 0.00% change from fiscal 2024.
- MYRIAD GENETICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2024 was 4.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 12 month |
|---|---|
| 2025-12-31 | 4.00% 10-K · filed 2026-02-24 |
| 2024-12-31 | 4.00% 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |